Simplification, standardisation & AI-enabled industry: Veeva...
Focused on innovating together, and together advancing industry, the Veeva R&D Summit this year highlighted an intention on one, AI-enabled cloud.
ASCO: BMS hails "compelling" phase 3 celmod readout
Bristol Myers Squibb has high hopes for its celmod drugs, and a phase 3 trial for mezigdomide in multiple myeloma at ASCO26 has delivered the goods.
Pharmacy First prescribing expanded to ease GP pressure
From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.
Review advises against broad NHS prostate cancer screening
The UK's National Screening Committee has concluded that the harms of widespread prostate cancer screening would outweigh its benefits.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Inizio Launches Intelligent Congress to Turn Event Investmen...
Inizio, the leading global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress
17th World ADC San Diego | October 12-15, 2026
The World’s Premier Forum to Advance Differentiated ADCs to Redefine Early-Line Oncology Patient Outcomes
6th Rare & Genetic Kidney Disease Drug Development Summit
The 6th Rare & Genetic Kidney Disease Drug Development Summit returns to Boston on August 18–20, 2026, bringing together global leaders advanc
Navigating Change: Key Industry Insights at PHARMAP 2026
PHARMAP returns in 2027 in Berlin, Germany, with Bayer as the Host Sponsor
Xcovery Partners with EVERSANA to Commercialize Lung Cancer ...
EVERSANA will provide comprehensive end-to-end commercialization services for Xcovery